Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schoppmann

Showing results (211-220 of 277) with videos related to

Pageof 28
Sort By:
Annals of the New York Academy of Sciences|May 19, 2018
Alternative therapies for GERD: a way to personalized antireflux surgeryErwin Rieder, Martin Riegler, Aleksandar P Simić, et al.
Anticancer Research|July 9, 2011
Docetaxel, cisplatin and 5-fluorouracil plus granulocyte colony-stimulating factor prophylaxis in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: experience at the Medical University of ViennaMarija Bojic, Ursula Pluschnig, Johannes Zacherl, et al.
Journal of Cancer Research and Clinical Oncology|October 14, 2024
Elevated fibrinogen-albumin ratio is an adverse prognostic factor for patients with primarily resected gastroesophageal adenocarcinomaGerd Jomrich, Winny Yan, Dagmar Kollmann, et al.
The British Journal of Surgery|May 28, 2011
HER-2 status in primary oesophageal cancer, lymph nodes and distant metastasesS F Schoppmann, B Jesch, J Zacherl, et al.
Molecular and Clinical Oncology|March 21, 2014
Lack of correlation between blood group and HER-2 status in adenocarcinomas of the upper gastrointestinal tractMichael Hejna, Peter Birner, Matthias Preusser, et al.
Anticancer Research|April 30, 2014
A phase II trial of two durations of Bevacizumab added to neoadjuvant gemcitabine for borderline and locally advanced pancreatic cancerKlaus Sahora, Martin Schindl, Irene Kuehrer, et al.
Cancers|November 9, 2024
Overexpression of Fibroblast Growth Factor 8 Is a Predictor of Impaired Survival in Esophageal Squamous Cell Carcinoma and Correlates with ALK/EML4 AlterationGerd Jomrich, Dagmar Kollmann, Winny Yan, et al.
The Journal of Comparative Neurology|April 8, 1987
Variability in hand surface representations in areas 3b and 1 in adult owl and squirrel monkeysM M Merzenich, R J Nelson, J H Kaas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 26, 2015
MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native EpitheliumJennifer Drahos, Katrin Schwameis, Linda D Orzolek, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|December 26, 2012
Identifying risk factors for allogenic blood transfusion in oral and oropharyngeal cancer surgery with free flap reconstructionChristos Perisanidis, Martina Mittlböck, Markus Dettke, et al.
Pageof 28

Showing results (211-220 of 277) with videos related to

Sort By:
Pageof 28
Annals of the New York Academy of Sciences|May 19, 2018
Alternative therapies for GERD: a way to personalized antireflux surgeryErwin Rieder, Martin Riegler, Aleksandar P Simić, et al.
Anticancer Research|July 9, 2011
Docetaxel, cisplatin and 5-fluorouracil plus granulocyte colony-stimulating factor prophylaxis in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: experience at the Medical University of ViennaMarija Bojic, Ursula Pluschnig, Johannes Zacherl, et al.
Journal of Cancer Research and Clinical Oncology|October 14, 2024
Elevated fibrinogen-albumin ratio is an adverse prognostic factor for patients with primarily resected gastroesophageal adenocarcinomaGerd Jomrich, Winny Yan, Dagmar Kollmann, et al.
The British Journal of Surgery|May 28, 2011
HER-2 status in primary oesophageal cancer, lymph nodes and distant metastasesS F Schoppmann, B Jesch, J Zacherl, et al.
Molecular and Clinical Oncology|March 21, 2014
Lack of correlation between blood group and HER-2 status in adenocarcinomas of the upper gastrointestinal tractMichael Hejna, Peter Birner, Matthias Preusser, et al.
Anticancer Research|April 30, 2014
A phase II trial of two durations of Bevacizumab added to neoadjuvant gemcitabine for borderline and locally advanced pancreatic cancerKlaus Sahora, Martin Schindl, Irene Kuehrer, et al.
Cancers|November 9, 2024
Overexpression of Fibroblast Growth Factor 8 Is a Predictor of Impaired Survival in Esophageal Squamous Cell Carcinoma and Correlates with ALK/EML4 AlterationGerd Jomrich, Dagmar Kollmann, Winny Yan, et al.
The Journal of Comparative Neurology|April 8, 1987
Variability in hand surface representations in areas 3b and 1 in adult owl and squirrel monkeysM M Merzenich, R J Nelson, J H Kaas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 26, 2015
MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native EpitheliumJennifer Drahos, Katrin Schwameis, Linda D Orzolek, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|December 26, 2012
Identifying risk factors for allogenic blood transfusion in oral and oropharyngeal cancer surgery with free flap reconstructionChristos Perisanidis, Martina Mittlböck, Markus Dettke, et al.
Pageof 28